A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma - Concepedia

Concepedia

Publication | Open Access

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma

DOI Full Paper Access

259

Citations

22

References

2019

Year

Patrick Y. Wen, David A. Reardon, Terri S. Armstrong, Surasak Phuphanich, Robert Aiken, Joseph Landolfi, William T. Curry, Jay‐Jiguang Zhu, Michael Glantz, David M. Peereboom,

Clinical Cancer Research

Abstract

PFS was significantly improved in ICT-107-treated patients with maintenance of QoL. Patients in the HLA-A2 subgroup showed increased ICT-107 activity clinically and immunologically.

References

	Year	Citations

Page 1